Read through our technical sheet on Mirabegron API to get a glimpse of our multi-step scalable synthetic approach with effective analytical characterization resulting in a highly pure API. 

Dr. Reddy's is among the earliest generic API manufacturers globally and filed the USDMF for Mirabegron API (α-form) in June 2014. We have also developed an amorphous form of Mirabegron, which has been filed in the US in February 2015.

Read the technical sheet on this topic by filling the contact form below.